| scholarly article | Q13442814 |
| P2093 | author name string | Feimeng Zhou | |
| Isba Silva | |||
| H Howard Xu | |||
| Matthew S Ward | |||
| Michael P Groziak | |||
| Ewa Kosmowska | |||
| Elena Buglo | |||
| Divya Kanichar | |||
| Shakila Rahman | |||
| Felicia Chow | |||
| Kim P Tran | |||
| Lance Roppiyakuda | |||
| Michelle A Faust | |||
| Jameka Jefferson | |||
| Jeanie M Garcia | |||
| Walfre Martinez | |||
| P2860 | cites work | Experimental Determination and System Level Analysis of Essential Genes in Escherichia coli MG1655 | Q22065459 |
| 10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America | Q24601746 | ||
| A mechanism of drug action revealed by structural studies of enoyl reductase | Q27734154 | ||
| Triclosan targets lipid synthesis | Q28279853 | ||
| A Pipeline for Screening Small Molecules with Growth Inhibitory Activity against Burkholderia cenocepacia | Q28548011 | ||
| Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America | Q29616084 | ||
| Complete set of ORF clones of Escherichia coli ASKA library (a complete set of E. coli K-12 ORF archive): unique resources for biological research | Q29619122 | ||
| High-throughput screening of a diversity collection using biodefense category A and B priority pathogens | Q30541139 | ||
| The discovery of biaryl acids and amides exhibiting antibacterial activity against Gram-positive bacteria | Q33199025 | ||
| Overproduction of beta-ketoacyl-acyl carrier protein synthase I imparts thiolactomycin resistance to Escherichia coli K-12 | Q33273138 | ||
| Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway | Q33314589 | ||
| Large-scale transposon mutagenesis of Mycoplasma pulmonis | Q33331457 | ||
| Dynamics of trimethoprim bound to dihydrofolate reductase | Q33576961 | ||
| Identification of critical staphylococcal genes using conditional phenotypes generated by antisense RNA. | Q33954835 | ||
| A missense mutation in the fabB (beta-ketoacyl-acyl carrier protein synthase I) gene confers tiolactomycin resistance to Escherichia coli. | Q34107208 | ||
| A genome-wide strategy for the identification of essential genes in Staphylococcus aureus | Q34123679 | ||
| Genome-wide saturation mutagenesis of Burkholderia pseudomallei K96243 predicts essential genes and novel targets for antimicrobial development | Q35092525 | ||
| A whole-cell assay for specific inhibitors of translation initiation in bacteria. | Q35542404 | ||
| Small molecules with antimicrobial activity against E. coli and P. aeruginosa identified by high-throughput screening | Q36054436 | ||
| Crystallographic insights into the structure-activity relationships of diazaborine enoyl-ACP reductase inhibitors. | Q36337901 | ||
| Mutants of Escherichia coli permeable to actinomycin | Q36453101 | ||
| The targets of currently used antibacterial agents: lessons for drug discovery | Q36990384 | ||
| Multiresistant Gram-negative infections: a global perspective | Q37783875 | ||
| Antisense PNA effects in Escherichia coli are limited by the outer-membrane LPS layer | Q38307812 | ||
| Activity of the ketolide telithromycin is refractory to Erm monomethylation of bacterial rRNA. | Q39651945 | ||
| Mechanism of action of diazaborines. | Q40854626 | ||
| Preparation and antibacterial activities of new 1,2,3-diazaborine derivatives and analogues | Q42248018 | ||
| Arabinose 5-phosphate isomerase as a target for antibacterial design: studies with substrate analogues and inhibitors. | Q43833813 | ||
| Synthesis, characterization, and antibacterial activity of structurally complex 2-acylated 2,3,1-benzodiazaborines and related compounds | Q46098028 | ||
| A disk-diffusion-based target identification platform for antibacterials (TIPA): an inducible assay for profiling MOAs of antibacterial compounds | Q46831959 | ||
| Over-expression of target genes as a mechanism of antibiotic resistance in bacteria. | Q52866894 | ||
| Antimicrobial activity of tryptanthrins in Escherichia coli. | Q54387789 | ||
| Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin. | Q54590227 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3267-3275 | |
| P577 | publication date | 2016-06-04 | |
| P1433 | published in | Bioorganic & Medicinal Chemistry | Q2904200 |
| P1476 | title | Identification of cellular targets of a series of boron heterocycles using TIPA II-A sensitive target identification platform | |
| P478 | volume | 24 |
Search more.